首页> 美国卫生研究院文献>Leukemia Research Reports >A primary esophageal MALT lymphoma patient with Helicobacter pylori infection achieved complete remission after H. pylori eradication without anti-lymphoma treatment
【2h】

A primary esophageal MALT lymphoma patient with Helicobacter pylori infection achieved complete remission after H. pylori eradication without anti-lymphoma treatment

机译:一名原发性食管MALT淋巴瘤感染的幽门螺杆菌患者在根除幽门螺杆菌后无需抗淋巴瘤治疗即可完全缓解

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Primary esophageal lymphoma is an extremely rare disease. We report a 76-year-old woman with esophageal lymphoma who achieved remission after Helicobacter pylori (HP) eradication. Esophagogastroduodenoscopy (EGD) revealed a mass in the lower esophagus, and she was diagnosed with stage IE mucosa-associated lymphoid tissue (MALT) lymphoma. She rejected any anti-lymphoma treatment except for HP eradication. Follow-up EGD demonstrated the disappearance of the esophageal MALT lymphoma 2 months after HP eradication, and she remained in remission for more than 3 years. Our results demonstrate that HP eradication may be effective as initial therapy in primary esophageal MALT lymphoma patients with HP infection.
机译:原发性食管淋巴瘤是一种极为罕见的疾病。我们报告了一名76岁的食管淋巴瘤妇女,在根除幽门螺杆菌(HP)后获得了缓解。食管胃十二指肠镜检查(EGD)显示食管下段有肿块,她被诊断患有IE期粘膜相关淋巴样组织(MALT)淋巴瘤。她拒绝除根除HP以外的任何抗淋巴瘤治疗方法。随访EGD证实,根除HP后2个月,食管MALT淋巴瘤消失,并且她的缓解期超过3年。我们的研究结果表明,根除HP可能有效地将原发性食管MALT淋巴瘤合并HP感染作为初始治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号